Sound Shore Management Inc CT Has $73.66 Million Stock Position in GE HealthCare Technologies Inc. $GEHC

Sound Shore Management Inc CT raised its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 14.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 980,756 shares of the company’s stock after acquiring an additional 125,062 shares during the quarter. GE HealthCare Technologies makes up 2.4% of Sound Shore Management Inc CT’s investment portfolio, making the stock its 27th largest holding. Sound Shore Management Inc CT’s holdings in GE HealthCare Technologies were worth $73,655,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in GEHC. Empowered Funds LLC lifted its position in GE HealthCare Technologies by 6.1% in the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after buying an additional 1,665 shares in the last quarter. Acadian Asset Management LLC acquired a new position in shares of GE HealthCare Technologies in the first quarter worth $259,000. Aberdeen Group plc raised its holdings in shares of GE HealthCare Technologies by 7.5% during the second quarter. Aberdeen Group plc now owns 112,065 shares of the company’s stock worth $8,301,000 after acquiring an additional 7,791 shares in the last quarter. Fifth Third Wealth Advisors LLC acquired a new stake in GE HealthCare Technologies during the second quarter valued at $210,000. Finally, Concurrent Investment Advisors LLC grew its stake in GE HealthCare Technologies by 31.6% in the second quarter. Concurrent Investment Advisors LLC now owns 8,529 shares of the company’s stock valued at $632,000 after purchasing an additional 2,049 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Stifel Nicolaus raised their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a research note on Wednesday, February 4th. Bank of America raised their price objective on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Barclays boosted their target price on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th. Evercore increased their price target on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Finally, Piper Sandler lifted their price objective on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a research note on Friday, January 30th. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $79.20 on Thursday. The company has a market cap of $36.10 billion, a price-to-earnings ratio of 17.37, a PEG ratio of 1.75 and a beta of 1.08. The business has a 50 day moving average price of $82.62 and a 200 day moving average price of $77.59. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The company had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the company earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.